Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sun Pharma Advanced Research Co. Ltd.

Latest From Ironwood Pharmaceuticals Inc.

Pipeline Watch: Phase III Starts For Itacitinib And AXS-05

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Ironwood Hits Endpoints In GERD, But Analysts Unimpressed With Treatment Effect

The GI specialty firm hopes it has a future blockbuster with the bile acid sequestrant after hitting multiple endpoints in Phase IIb, but the treatment effect compared to PPI therapy alone was below what was previously anticipated.

Clinical Trials Gastrointestinal

EMA, FDA Talk Real World Evidence, Mutual Recognition, Generic Drugs

US FDA and European Medicines Agency may expand sharing beyond manufacturing inspections to clinical trials and generic drug applications.

FDA Drug Approval Standards

Keeping Track: First Gliomas Imaging Agent Wins Approval; Amgen Hopes New Repatha Data Boosts Prospects

The latest drug development news and US FDA highlights from our Performance Tracker.

Approvals Drug Review
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
    • Nanotechnology, Chips, etc.
  • Medical Devices
    • Biomaterials
    • Implantable Devices
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Pulmonary
  • Therapeutic Areas
  • Cancer
  • Inflammation
  • Musculoskeletal & Connective Tissue Disorders
  • Ophthalmic
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Sun Pharma Advanced Research Co. Ltd.
  • Senior Management
  • Anil Raghavan, CEO
    Sudhir V Valia, CFO
    T. Rajamannar, PhD, EVP, R&D
  • Contact Info
  • Sun Pharma Advanced Research Co. Ltd.
    Phone: 22 6645 5645
    17B Mahal Industrial Estate
    Mahakali Caves
    Mumbai, 400-093